clinicaltrialsarena26m
Gilead’s Livdelzi shows promise in PBC clinical trial
Gilead Sciences has reported two-and-a-half-year interim analysis outcomes from a Phase III study of Livdelzi (seladelpar) ...
clinicaltrialsarena2h
Eyenovia stock plummets following Phase III myopia trial failure
The failure of the Eyenovia CHAPERONE study has seen the company’s stock value drop drastically as it weighs up options and ...
clinicaltrialsarena15h
Men’s Health Awareness Month promotes early prostate cancer detection
GlobalData forecasts that the prostate cancer market is set to increase by 25% from $475.84 million in 2024 to $596.22 ...
clinicaltrialsarena15h
Eli Lilly reports outcomes from Phase III trial of tirzepatide for HFpEF
The study involved 731 participants who were randomised to receive either tirzepatide or placebo. Credit: Africa Studio/Shutterstock. Eli Lilly has reported comprehensive outcomes from the Phase III ...